Edge Pharma, LLC is recalling 48 syringes of Ceftazidime Sterile Ophthalmic Solution (22.5mg/ml), an injectable medication used for intraocular treatment. The recall was initiated because the testing media used to confirm the sterility of the product after compounding was expired, meaning the company cannot guarantee the medication is free from contamination. This compounded drug was distributed nationwide to hospitals and medical offices in 0.5ml single-use syringes.
Using a medication that lacks assurance of sterility poses a risk of introducing bacteria or fungi directly into the eye during injection. This can lead to serious infections, potential vision loss, or other systemic health complications, particularly for patients with compromised immune systems.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.